NCT01864031

Brief Summary

The association between alcohol consumption and cardiovascular disease (CVD) has mostly been examined using broad endpoints or cause-specific mortality. The purpose of our study is to compare the effect of alcohol consumption in the aetiology of a range of cardiovascular disease phenotypes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,240,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1997

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1997

Completed
16.4 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 29, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

May 29, 2013

Status Verified

May 1, 2013

Enrollment Period

16.9 years

First QC Date

May 23, 2013

Last Update Submit

May 28, 2013

Conditions

Keywords

AlcoholDrinkingAbstainersFormer drinkersEx-drinkersAetiologyInitial presentationChronic Stable AnginaUnstable AnginaCoronary Heart Disease Not Otherwise SpecifiedAcute Myocardial InfarctionHeart FailureST elevation Myocardial Infarction (STEMI)non-ST elevation Myocardial Infarction (nSTEMI)Myocardial Infarction Not Otherwise Specified (MI NOS)Ventricular ArrhythmiasCardiac ArrestAbdominal Aortic AneurysmPeripheral Arterial DiseaseIschaemic StrokeSubarachnoid Haemorrhagic StrokeIntracerebral haemorrhagic StrokeStroke Not Otherwise SpecifiedSudden Cardiac DeathUnheralded Coronary DeathMortalityCoronary Heart Disease (CHD)Cardiovascular Disease (CVD)Fatal Cardiovascular Disease (fatal CVD)

Outcome Measures

Primary Outcomes (1)

  • Initial presentation of cardiovascular disease

    See "Conditions" and "Detailed Description" sections for further description of the endpoints used.

    Study follow-up will commence on the earliest date that a patient fulfils the study inclusion criteria during the period between 1st January 1997 and 25th March 2010 (maximum of 13 years follow-up)

Secondary Outcomes (1)

  • Non-CVD mortality

    Same as for primary outcomes (maximum of 13 years follow-up)

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The cohort used in the present study was drawn from patients registered with GPRD general practices in England that consented to data linkage (approx. 5% of the UK population). We used an open cohort design, where participants joined the cohort when they met the inclusion criteria at any point between 1st January 1997 and 25th March 2010 (the last GPRD data submission). Patients were included in cohort if they were aged ≥ 30 years, had at least one year of electronic health record data which met GPRD data quality standards, and had no record indicating any cardiovascular disease prior to study entry. Patients were followed up until the date of an initial presentation of one of our cardiovascular endpoints or were censored on the date of leaving the practice/last data submission from their practice. Patients who died before 1st January 2001 were excluded as cause-specific mortality data was not available for them (this approach is adopted in the Prospective Studies Collaboration).

You may qualify if:

  • Aged ≥ 30 years.
  • Patient in a GPRD registered practice that has consented to the linkage process (who also met data quality standards).

You may not qualify if:

  • A recorded history of any cardiovascular disease phenotype prior to entering the study.
  • Cause of death unknown.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College London

London, United Kingdom

Location

Related Publications (6)

  • Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011 Feb 22;342:d671. doi: 10.1136/bmj.d671.

    PMID: 21343207BACKGROUND
  • Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012 Jul;107(7):1246-60. doi: 10.1111/j.1360-0443.2012.03780.x. Epub 2012 Mar 21.

    PMID: 22229788BACKGROUND
  • Mukamal K. Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol. 2007 May;17(5 Suppl):S8-S12. doi: 10.1016/j.annepidem.2007.01.003.

    PMID: 17478332BACKGROUND
  • Stockwell T, Greer A, Fillmore K, Chikritzhs T, Zeisser C. How good is the science? BMJ. 2012 Mar 27;344:e2276; author reply e2294. doi: 10.1136/bmj.e2276. No abstract available.

    PMID: 22453883BACKGROUND
  • Denaxas SC, George J, Herrett E, Shah AD, Kalra D, Hingorani AD, Kivimaki M, Timmis AD, Smeeth L, Hemingway H. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol. 2012 Dec;41(6):1625-38. doi: 10.1093/ije/dys188. Epub 2012 Dec 5.

    PMID: 23220717BACKGROUND
  • Bell S, Daskalopoulou M, Rapsomaniki E, George J, Britton A, Bobak M, Casas JP, Dale CE, Denaxas S, Shah AD, Hemingway H. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017 Mar 22;356:j909. doi: 10.1136/bmj.j909.

Related Links

MeSH Terms

Conditions

Angina, StableAngina, UnstableHeart FailureHeart ArrestAortic Aneurysm, AbdominalPeripheral Arterial DiseaseIschemic StrokeDeath, Sudden, CardiacCoronary DiseaseCardiovascular DiseasesST Elevation Myocardial InfarctionNon-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAortic AneurysmAneurysmAortic DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesPeripheral Vascular DiseasesStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesDeath, SuddenDeathPathologic ProcessesMyocardial InfarctionInfarctionIschemiaNecrosis

Study Officials

  • Steven Bell, PhD

    University College, London

    PRINCIPAL INVESTIGATOR
  • Harry Hemingway, FRCP

    University College, London

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Epidemiology

Study Record Dates

First Submitted

May 23, 2013

First Posted

May 29, 2013

Study Start

January 1, 1997

Primary Completion

December 1, 2013

Study Completion

December 1, 2014

Last Updated

May 29, 2013

Record last verified: 2013-05

Locations